Veracity Capital LLC Galapagos Nv Transaction History

Veracity Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 13, 2020	SELL	$185.52 - $231.25 $394,044 - $491,175	-2,124 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$143.0 - $274.03 $31,174 - $59,738	-218 Reduced 9.31%	2,124 $416,000
Q4 2019 May 07, 2020	BUY	$146.12 - $215.82 $342,213 - $505,450	2,342 New	2,342 $484,000

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.88B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Veracity Capital LLC with notifications on news.